Metastasis, the spreading of cancer cells to other parts of the body, contributes to 9 out of 10 cancer-related deaths. However, the intricate mechanisms triggering this process remain a mystery. 3DSecret is on a mission to change that. The European consortium 3DSecret, coordinated by INL researchers from the Medical Devices research group, is approaching metastasis in a new way, focusing on single cells and aiming to uncover hidden patterns that can predict and forecast how cancer spreads. “By studying individual circulating tumour cells, or CTCs, 3DSecret hopes to transform how cancer is diagnosed and/or treated, making significant strides in clinical sciences”, says Miguel Xavier, technical coordinator of the 3DSecret project. In response to this challenge, 3DSecret has outlined specific objectives. At the forefront is the development of the ‘3Dsecret-chip,’ a sophisticated tool designed to facilitate the controlled creation of 3D cancer cell models from individual cells. This innovative approach promises reproducibility and precision, enhancing one’s ability to examine the details of cancer cell behaviour. Furthermore, 3DSecret is incorporating ‘SERS metabolomics profiling’, an advanced technology providing continuous insights into the growth kinetics of these 3D cancer cell models. Sara Abalde-Cela, leader of the Medical Devices research group and coordinator of the […]
Read more